FDA Approved: ARSENIC TRIOXIDE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for arsenic trioxide from Zydus Pharmaceuticals USA Inc. under ANDA206228.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Promyelocytic Leukemia

Drugs mentioned

• Arsenic Trioxide (arsenic trioxide)

Snippet

SUPPL AP for ARSENIC TRIOXIDE (ARSENIC TRIOXIDE)